Mycological-epidemiological aspects of CVV and their risk factors
DOI:
https://doi.org/10.55312/op.vi2.4522Abstract
Vulvovaginal candidiasis (VVC) is a comon cause of feminine genital tract infection encountered in medical practice. Not much information regarding its incidence and epidemiology is available. In this prospective study, 514 vaginal swabs were collected over e period of 1 year. After recording their relevant personal and reproductive history, vaginal secretions were culture on Sabouraud dextrose agar (SDA) medium. Candida species were identifi ed by a series of morphological and biochemical tests. Statistical analysis was done by using Chi-square test. Positive culture for Candida species was obtained in 120 (25.4%) women. Candida albicans was isolated most frequently (78.4%) , and (21.6%) were non C . albicans.Keywords:
vulvovaginal candidiasis, risk factors, prevalence.Downloads
References
-
E. N. Ringdahl, Treatment of recurrent vulvovaginal candidiasis, Am. Fam. Physician (2000), p. 3306-3312.
-
B. R. Rowe, M.N. Logan, I. Farrell and A.H. Barnett, Is candidiasis the true cause of vulvovaginal irritation in women with diabetes mellitus?, J. Clin. Pathol. (1990), pp. 644–645.
-
E. Rylander, A.L. Berglund, C. Krassny andB. Petrini, Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse, Sex. Transm. Inf. (2004), pp. 54–57.
-
J. M. Senterre, M. Car pentier and J.M. Foidart, Prévalence des diff érentes espèces de Candida au niveau vaginal dans la région Liégeoise, Rev. Med. Liege (2005), pp. 882–884.
-
A. Spinillo, E. Cappuzzo, S. Acciano, A. De Santolo and F. Zara, Eff ect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis, Am. J. Obstet. Gynecol. (1999), pp. 14–17.
-
T. G. M. Bauters, M.A. Dhont, M.I.L. Temmerman and H. J. Nelis, Prevale nce of vulvovaginal candidiasis and susceptibility to fl uconazole in women, Am. J. Obstet. Gynecol. (2002), pp. 569–574.
-
V. Bohannon, Treatment of vulvovaginal candidiasis in patien ts with diabetes, Diabetes Care (1998), pp. 451–456.
-
R. Bouguerra, O. Essaïs, N. Sebaï, L. Ben Salem, H. Amari and M. R. Kammoun et al., Prévalence et aspects cliniques des mycoses superfi cielles, Med. Mal. Inf. (2004), pp. 201–205.
-
F. Chassot, M.F.N. Negri, A. E. Svidzinski, L. Donatti, R. M. Peralta and T. I. E. Svidzinski et al., Can intrauterine devices be a C andida albicans reservoir?, Contraception (2008), pp. 355–359.
-
E. M. De leon, S.J. Jacober, J. D. Sobel and B. Foxm an, Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes, BMC Infect. Dis. (2002), pp. 1–6.
-
S. Demirezen, O. O. Dirlik and M. S. B eksac, The association of Candida infection with intrauterine contraceptive device, Cent. Eur. J. Public Health (2005), pp. 32–34.
-
H. Fox, Genital candidosis in general practice, J. R. Coll. Gen. Pract. (1984 ), pp. 449–450.
-
B. Foxman, The epidemiology of vulvovaginal candidiasis: risk factors, Am. J. Public Health (1990), pp. 329–331.
-
D. D. Glover and B. Larsen, Relationship of fungal vaginitis th erapy to prior antibiotic exposure, Infect. Dis. Obstet. Gynecol.
-
(2003), pp. 157–160.
-
O. Grigoriou, S. Baka, E. Makrakis, D. Hassiakos, G. Kapparos and E. Kouskoun i, Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors, Eur. J . Obstet. Gynecol. Reprod. Biol. (2006), pp. 121–125.
-
N. N. S. Hodoglugil, D. Aslan and M. Bertan, Intrauterine d evice use and some ssues related to sexually transmitted disease screening and occurrence, Contraception (2000), pp. 359–364.
-
N. Jindal, P. Gill, A. Aggarwal. An epidemiological study of vulvovaginal candidiasis in women of childbearing age. www.ijmm.org. 25 (2007) 175–6.
-
J. D. Sobel, Vulvovaginal candidosis, Lancet (2007), pp. 1961–1971.
-
O. T. Malazy, M. Shariat, R. Heshmat, F. Majlesi, M. Alimohammadian and N. K. Tabari et al., Vulvovaginal candidiasis
-
and its related factors in diabetic women, Taiwan J. Obstet. Gynecol. (2007), pp. 399–404.
References
E. N. Ringdahl, Treatment of recurrent vulvovaginal candidiasis, Am. Fam. Physician (2000), p. 3306-3312.
B. R. Rowe, M.N. Logan, I. Farrell and A.H. Barnett, Is candidiasis the true cause of vulvovaginal irritation in women with diabetes mellitus?, J. Clin. Pathol. (1990), pp. 644–645.
E. Rylander, A.L. Berglund, C. Krassny andB. Petrini, Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse, Sex. Transm. Inf. (2004), pp. 54–57.
J. M. Senterre, M. Car pentier and J.M. Foidart, Prévalence des diff érentes espèces de Candida au niveau vaginal dans la région Liégeoise, Rev. Med. Liege (2005), pp. 882–884.
A. Spinillo, E. Cappuzzo, S. Acciano, A. De Santolo and F. Zara, Eff ect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis, Am. J. Obstet. Gynecol. (1999), pp. 14–17.
T. G. M. Bauters, M.A. Dhont, M.I.L. Temmerman and H. J. Nelis, Prevale nce of vulvovaginal candidiasis and susceptibility to fl uconazole in women, Am. J. Obstet. Gynecol. (2002), pp. 569–574.
V. Bohannon, Treatment of vulvovaginal candidiasis in patien ts with diabetes, Diabetes Care (1998), pp. 451–456.
R. Bouguerra, O. Essaïs, N. Sebaï, L. Ben Salem, H. Amari and M. R. Kammoun et al., Prévalence et aspects cliniques des mycoses superfi cielles, Med. Mal. Inf. (2004), pp. 201–205.
F. Chassot, M.F.N. Negri, A. E. Svidzinski, L. Donatti, R. M. Peralta and T. I. E. Svidzinski et al., Can intrauterine devices be a C andida albicans reservoir?, Contraception (2008), pp. 355–359.
E. M. De leon, S.J. Jacober, J. D. Sobel and B. Foxm an, Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes, BMC Infect. Dis. (2002), pp. 1–6.
S. Demirezen, O. O. Dirlik and M. S. B eksac, The association of Candida infection with intrauterine contraceptive device, Cent. Eur. J. Public Health (2005), pp. 32–34.
H. Fox, Genital candidosis in general practice, J. R. Coll. Gen. Pract. (1984 ), pp. 449–450.
B. Foxman, The epidemiology of vulvovaginal candidiasis: risk factors, Am. J. Public Health (1990), pp. 329–331.
D. D. Glover and B. Larsen, Relationship of fungal vaginitis th erapy to prior antibiotic exposure, Infect. Dis. Obstet. Gynecol.
(2003), pp. 157–160.
O. Grigoriou, S. Baka, E. Makrakis, D. Hassiakos, G. Kapparos and E. Kouskoun i, Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors, Eur. J . Obstet. Gynecol. Reprod. Biol. (2006), pp. 121–125.
N. N. S. Hodoglugil, D. Aslan and M. Bertan, Intrauterine d evice use and some ssues related to sexually transmitted disease screening and occurrence, Contraception (2000), pp. 359–364.
N. Jindal, P. Gill, A. Aggarwal. An epidemiological study of vulvovaginal candidiasis in women of childbearing age. www.ijmm.org. 25 (2007) 175–6.
J. D. Sobel, Vulvovaginal candidosis, Lancet (2007), pp. 1961–1971.
O. T. Malazy, M. Shariat, R. Heshmat, F. Majlesi, M. Alimohammadian and N. K. Tabari et al., Vulvovaginal candidiasis
and its related factors in diabetic women, Taiwan J. Obstet. Gynecol. (2007), pp. 399–404.
Shqip
English
Italiano
